HYOU1 anticorps (FITC)

N° du produit ABIN2868640

Détail du produit anti-HYOU1 anticorps (FITC)

Antigène: HYOU1 (Hypoxia Up Regulated 1 (HYOU1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp HYOU1 est conjugé à/à la FITC

Application: Western Blotting (WB), Immunofluorescence (IF), Immunocytochemistry (ICC)

Specificité: Detects ~170 kDa.

Réactivité croisée: Humain, Souris, Rat

Purification: Protein G Purified

Immunogène: Recombinant Full length GRP170 Protein

Clone: 6E3-2C3

Isotype: IgG2b

Information d'application

Indications d'application:

• WB (1:1000)
• ICC/IF (1:100)
• optimal dilutions for assays should be determined by the user.

Commentaires:

1 μg/ml of ABIN2868640 was sufficient for detection of GRP170 in 20 μg of HEK293 lysate by colorimetric immunoblot analysis using Goat anti-mouse IgG:HRP as the secondary antibody.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS pH 7.4, 50 % glycerol, 0.1 % sodium azide, Storage buffer may change when conjugated

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: Conjugated antibodies should be stored at 4°C

Détails sur HYOU1

Antigène: HYOU1 (Hypoxia Up Regulated 1 (HYOU1))

Autre désignation: GRP170 (HYOU1 Produits)

Synonymes: anticorps GRP-170, anticorps Grp170, anticorps HSP12A, anticorps ORP-150, anticorps ORP150, anticorps AI415631, anticorps CBP-140, anticorps Cab140, anticorps Orp150, anticorps id:ibd5056, anticorps wu:fd14c05, anticorps zgc:56019, anticorps HYOU1, anticorps orp150, anticorps GRP170, anticorps hypoxia up-regulated 1, anticorps hypoxia up-regulated protein 1, anticorps hypoxia up-regulated 1 S homeolog, anticorps HYOU1, anticorps Hyou1, anticorps hyou1, anticorps LOC100380749, anticorps hyou1.S

Sujet: GRP170, also known as ORP150, is the largest member of glucose-regulated Antibodys, and acts as a human chaperone Antibody. It is thought to play an important role in Antibody folding and secretion in the ER. Suppression of the Antibody is associated with accelerated apoptosis, therefore having an important cryoprotective role in hypoxia-induced cellular pertubation. This cryopotective role has led to an anti-tumor immune response, which will hopefully lead to therapeutic immunizations against cancers (1). GRP170 has also been shown to bind with dendritic cells and provide the danger signals to induce anti-tumor immune responses (2).

ID gène: 10525

NCBI Accession: NP_006389

UniProt: Q9Y4L1

Pathways: ER-Nucleus Signaling, SARS-CoV-2 Protein Interactome